IRIX
IRIDEX CORP
NASDAQ · Healthcare · Medical - Devices · US
$0.71
+1.31%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$0.69
From 52W high−54.80%
Volume4815.00
Market cap$12.39M
P/E (TTM)—
P/S (TTM)0.2x
Div yield—
Key dataNov 4, 2026
Open
$0.69
From 52W high
−54.80%
Volume
4815.00
Market cap
$12.39M
ValuationView details →
P/E (Fwd)
35.3x
EV/EBITDA
−10.4x
P/E (TTM)
—
RSI (14)
46.8
MomentumView details →
1D Return
+1.31%
YTD Return
−35.82%
SummaryUpdated Jul 1, 2026
IRIDEX Corporation (NASDAQ:IRIX) is a specialized ophthalmic medical technology company founded in 1989 and headquartered in Mountain View, California. The company went public in 1996 and has established itself as a provider of therapeutic laser systems and related devices for treating sight-threatening eye diseases. IRIDEX focuses primarily on two major areas of ophthalmology: glaucoma and retinal disorders, serving eye care professionals worldwide through both direct sales and international distribution networks.
Similar companies
Latest newsMore news →
Iridex announced that it will release its third-quarter 2026 financial results and provide a business update after the close of trading on November 17, 2026.19h agoIridex completed the relocation of its manufacturing facility to San Jose, California, expecting about $600,000 in annualized cost savings.30d ago